Results 81 to 90 of about 581,626 (194)

Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. [PDF]

, 2014
An exponential increase in the use of transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis has been witnessed over the recent years. The current article reviews different areas of uncertainty related to patient selection.
Rodés-Cabau, Josep, Roberts, William C. (William Clifford), Hamm, Christian W., Thomas, Martyn, Hamm, Christian, Erbel, Raimund, Kappetein, Arie P, Zamorano, Jose Luis, Webb, John, Collet, Jean P., Serruys, P. W., Roberts, William C, Vahanian, Alec, Webb, John G. (John Graydon), Pibarot, Philippe, Bax, Jeroen J, Bapat, Vinayak, Windecker, Stephan, Collet, Jean P, Piazza, Nicolo, Leipsic, Jonathon, MacCarthy, Philip, Kappetein, A. P., Delgado, Victoria, Bax, Jeroen J., Zamorano, José L. (José Luis), Baumgartner, Helmut, Leon, Martin B., Leon, Martin B, Serruys, Patrick W   +29 more
core   +2 more sources

Anesthetic considerations of percutaneous transcatheter aortic valve implantation: first attempt in Korea -A report of 2 cases- [PDF]

Korean Journal of Anesthesiology, 2011
Conventional aortic valve replacement for severe aortic stenosis is associated with a high operative mortality in the elderly patients with significant comorbidities, including severe respiratory dysfunction, renal insufficiency, and compromised cardiac ...
Hyo Jung Son, Hwa Mi Lee, Ji Hyun Chin, Dae Kee Choi, Eun Ho Lee, Ji Yeon Sim, In Cheol Choi   +6 more
doaj   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

Therapeutic‐dose verapamil‐induced cardiogenic shock in an older patient: a case report

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background Calcium channel blocker (CCB) toxicity most commonly follows deliberate overdose. However, severe toxicity at therapeutic doses may occur in susceptible individuals. Severe CCB toxicity often presents with clinical features of bradycardia, hypotension, hyperglycaemia, and lactic acidosis.
Christopher Thuring, Maria Carey, Timothy Webber, Biswadev Mitra   +3 more
wiley   +1 more source

Sustained Improvement of Left Ventricular Strain following Transcatheter Aortic Valve Replacement

, 2019
PURPOSE: Left ventricular (LV) mechanics are impaired in patients with severe aortic stenosis (AS). Transcatheter aortic valve replacement (TAVR) has become a widespread technique for patients with severe AS considered inoperable or high risk for open ...
Echeverría García, T., Habib, G., La Canna, G., Fernández-Golfín, C., Plaza Martín, M., de la Hera Galarza, J. M., López-Fernández, T., Lozano Granero, V. C., Fernández Santos, S., Faletra, F. F., Mesa, D., González Gómez, A., Zamorano Gómez, J. L., Swaans, M. J., Martínez Monzonís, Maria Amparo   +14 more
core   +1 more source

Transapical transcatheter aortic valve implantation using the second-generation self-expanding Symetis ACURATE TA valve [PDF]

, 2014
Transapical transcatheter aortic valve implantation (TA-TAVI) is the recognized first choice surgical TAVI access. Expansion of this well-established treatment modality with subsequent broader patient inclusion has accelerated development of second ...
Windecker, Stephan, Huber, Christoph, Carrel, Thierry, Wenaweser, Peter Martin   +3 more
core   +1 more source

Sleep‐disordered breathing in valvular heart disease: A Modifiable comorbidity

Sleep Research, EarlyView.
Abstract Sleep‐disordered breathing (SDB) is highly prevalent among patients with valvular heart disease (VHD) and is independently associated with adverse clinical outcomes. The two major phenotypes—obstructive sleep apnea (OSA) and central sleep apnea (CSA)—exhibit distinct distributions across VHD subtypes. CSA predominates in severe aortic stenosis,
Wu Juan, Chen Ze, Zhang Qun, Chen Qiuyuan, Su Mei, Zhang Xilong, Ding Ning   +6 more
wiley   +1 more source

Transcatheter aortic valve implantation or surgical aortic valve replacement as redo procedure after prior coronary artery bypass grafting

, 2011
The perioperative risk for redo surgical aortic valve replacement (S-AVR) in patients with severe aortic stenosis and prior coronary artery bypass grafting (CABG) is increased. Transcatheter aortic valve implantation (TAVI) represents an alternative.
Thierry Carrel, Windecker, Stephan, Henriette Brinks, Thomas Pilgrim, Peter Wenaweser, Brinks, Henriette, Wenaweser, Peter, Christoph Huber, Stortecky, Stefan, Huber, Christoph, Carrel, Thierry, Stephan Windecker, Pilgrim, Thomas, Kadner, Alexander, Stefan Stortecky, Alexander Kadner   +15 more
core   +1 more source

Reoperative aortic valve replacement in the era of valve‐in‐valve procedures

Clinical Case Reports, 2020
Current evidence suggests that the choice between valve‐in‐valve transcatheter aortic valve implantation and reoperative aortic valve replacement should be based on multiple factors.
Daisuke Kaneyuki, Hiroyuki Watanabe, Masayoshi Otsu, Hiroaki Yamamoto   +3 more
doaj   +1 more source

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

Artificial Organs, EarlyView.
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov, Sara Yousefzada, Isabell A. Just, Christoph Klein, Evgenij Potapov, Santiago Garcia, Dhairya Patel, Lauren S. Ranard, Arseniy Goncharov, Dean J. Kereiakes, Raj R. Makkar, Torsten P. Vahl, Tanja K. Rudolph, Axel Unbehaun   +13 more
wiley   +1 more source